Impact of supervised gene signatures of early hypoxia on patient survival

Radiotherapy and Oncology

Volumn 83, Issue 3, 2007, Pages 374-382

  Seigneuric, Renaud ^a   Starmans, Maud H W ^a   Fung, Glenn ^b   Krishnapuram, Balaji ^b   Nuyten, Dimitry S A ^c   van Erk, Arie ^d   Magagnin, Michael G ^a   Rouschop, Kasper M ^a   Krishnan, Sriram ^b   Rao, R Bharat ^b   Evelo, Chris T A ^d   Begg, Adrian C ^c   Wouters, Bradly G ^a   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gene Expression Signature; Hypoxia; Insulin; Molecular medicine; Time series

Indexed keywords

INSULIN; OXYGEN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER SURVIVAL; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; KAPLAN MEIER METHOD; LYMPH NODE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; UNIVARIATE ANALYSIS; UPREGULATION;

CELL HYPOXIA; DATABASES, GENETIC; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MIDDLE AGED; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 34250323878     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.05.002     Document Type: Article

References (23)

1. Bild A.H., Potti A., and Nevins J.R. Linking oncogenic pathways with therapeutic opportunities. Nat Rev Cancer 6 (2006) 735-741
2. Bussink J., Kaanders J.H., and van der Kogel A.J. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy. Radiother Oncol 82 (2007) 10-17
3. Chang H.Y., Sneddon J.B., Alizadeh A.A., et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2 (2004) E7
4. Chi J.T., Wang Z., Nuyten D.S., et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 3 (2006) e47
5. Chung C.H., Bernard P.S., and Perou C.M. Molecular portraits and the family tree of cancer. Nat Genet 32 (2002) 533-540
6. Denko N.C., Fontana L.A., Hudson K.M., et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 (2003) 5907-5914
7. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998) 14863-14868
8. Eriksen J.G., and Horsman M.R. Tumour hypoxia - a characteristic feature with a complex molecular background. Radiother Oncol 81 (2006) 119-121
9. Huang E.S., Black E.P., Dressman H., West M., and Nevins J.R. Gene expression phenotypes of oncogenic signaling pathways. Cell Cycle 2 (2003) 415-417
10. Iyer V.R., Eisen M.B., Ross D.T., et al. The transcriptional program in the response of human fibroblasts to serum. Science 283 (1999) 83-87
11. Kietzmann T., Krones-Herzig A., and Jungermann K. Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. Biochem Pharmacol 64 (2002) 903-911
12. Koritzinsky M., Seigneuric R., Magagnin M.G., van den Beucken T., Lambin P., and Wouters B.G. The hypoxic proteome is influenced by gene-specific changes in mRNA translation. Radiother Oncol 76 (2005) 177-186
13. Miller L.D., Smeds J., George J., et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102 (2005) 13550-13555
14. Ramaswamy S., Tamayo P., Rifkin R., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98 (2001) 15149-15154
15. Riedemann J., and Macaulay V.M. IGF1R signalling and its inhibition. Endocr Relat Cancer 13 (2006) S33-S43
16. Sjogren S., Inganas M., Norberg T., et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 88 (1996) 173-182
17. Smith P.F. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I). IDrugs 6 (2003) 1173-1177
18. Sorensen B.S., Hao J., Overgaard J., et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 76 (2005) 187-193
19. 18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. Radiother Oncol 80 (2006) 157-164
20. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
21. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
22. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 9 (2004) 10-17
23. Wouters B.G., van den Beucken T., Magagnin M.G., Lambin P., and Koumenis C. Targeting hypoxia tolerance in cancer. Drug Resist Updat 7 (2004) 25-40